SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-168,000
-300,000 vol
$0.56 each 		242,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-27,500
-50,000 vol
$0.55 each 		542,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-31,500
-50,000 vol
$0.63 each 		42,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-30,500
-50,000 vol
$0.61 each 		92,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-29,500
-50,000 vol
$0.59 each 		142,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-28,500
-50,000 vol
$0.57 each 		192,971
Filed 2018-01-02
Tx date 2017-12-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,575
-26,500 vol
$0.55 each 		592,971
Filed 2017-12-20
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$20,999
+48,837 vol
$0.43 each 		619,471
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-18,427.50
-40,500 vol
$0.455 each 		620,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,250
-50,000 vol
$0.305 each 		661,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-24,500
-50,000 vol
$0.49 each 		711,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-23,500
-50,000 vol
$0.47 each 		761,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-4,370
-9,500 vol
$0.46 each 		811,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-16,500
-50,000 vol
$0.33 each 		820,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,750
-50,000 vol
$0.315 each 		910,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-12,800
-40,000 vol
$0.32 each 		870,634
Filed 2017-12-18
Tx date 2017-12-15 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-33,000
-50,000 vol
$0.66 each 		570,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,500
-50,000 vol
$0.29 each 		1,170,634
Filed 2017-11-29
Tx date 2017-11-28 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-3,200
-10,000 vol
$0.32 each 		960,634
Filed 2017-11-29
Tx date 2017-11-28 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,750
-50,000 vol
$0.315 each 		970,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-24,500
-100,000 vol
$0.245 each 		1,070,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,250
-50,000 vol
$0.265 each 		1,320,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,750
-50,000 vol
$0.275 each 		1,270,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,250
-50,000 vol
$0.285 each 		1,220,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,000
-50,000 vol
$0.28 each 		1,020,634
Filed 2017-11-27
Tx date 2017-11-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,500
-50,000 vol
$0.23 each 		1,370,634
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,500
-50,000 vol
$0.23 each 		1,644,134
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-22,500
-100,000 vol
$0.225 each 		1,544,134
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,405
-23,500 vol
$0.23 each 		1,520,634
Filed 2017-11-27
Tx date 2017-11-23 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,250
-50,000 vol
$0.225 each 		1,470,634
Filed 2017-11-27
Tx date 2017-11-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,250
-50,000 vol
$0.225 each 		1,420,634
Filed 2017-11-01
Tx date 2017-10-30 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$7,352
+52,972 vol
$0.1388 each 		1,694,134
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,504
+96,551 vol
$0.1088 each 		1,641,162
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,493
+121,739 vol
$0.0862 each 		1,544,611
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$36,250
+250,000 vol
$0.145 each 		1,422,872
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,504
+96,551 vol
$0.1088 each 		1,172,872
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$46,250
+250,000 vol
$0.185 each 		1,076,321
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,503
+75,675 vol
$0.1388 each 		826,321
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services 		$10,500
+70,000 vol
$0.15 each 		750,646
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		680,646
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$60,000
+500,000 vol
$0.12 each 		892,687
Filed 2017-03-14
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-14
Tx date 2017-03-13 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$21,009
+180,646 vol
$0.1163 each 		180,646
Filed 2017-03-06
Tx date 2017-03-03 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-26,021.325
-157,705 vol
$0.165 each 		392,687
Filed 2017-01-23
Tx date 2017-01-17 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$10,505
+103,704 vol
$0.1013 each 		550,392
Filed 2017-01-16
Tx date 2017-01-13 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,520
-18,000 vol
$0.14 each 		446,688
Filed 2017-01-12
Tx date 2017-01-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,100
-165,000 vol
$0.14 each 		464,688
Filed 2016-12-14
Tx date 2016-12-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$5,249
+53,846 vol
$0.0975 each 		629,688
Filed 2016-11-22
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$5,250
+43,750 vol
$0.12 each 		575,842
Filed 2016-11-22
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		532,092